On ECHEMI
Home > Drugs > diabetes
diabetes
Diabetes is a common disease caused by the interaction of genetic and environmental factors. The main clinical sign is high blood sugar. Common symptoms include polydipsia, polyuria, polyphagia, and weight loss. Diabetes can cause damage to multiple systems in the body, leading to absolute or relative insulin deficiency and reduced insulin sensitivity of target tissue cells, causing a series of metabolic disorders such as protein, fat, water, and electrolytes. Significant increase in blood sugar can cause acute complications such as diabetic ketoacidosis and hyperosmolar coma. Long-term illness can also cause vascular and neuropathy, resulting in damage to multiple organs and tissues such as the heart, brain, kidneys, eyes, nerves, and skin, affecting the patient's quality of life and even shortening life expectancy. Active prevention and treatment should be carried out.
Related Drugs
Metformin and Glibenclamide Tablets (Ⅰ)
Indication: 1. For patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by diet control and/or exercise therapy alone. 2. Can be used as a second-line drug for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by sulfonylurea or metformin hydrochloride alone.
Manufacturer:

Changzhou Pharmaceutical Factory Co., Ltd.

Metformin and Glibenclamide Tablets (Ⅰ)
Indication: 1. For patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by diet control and/or exercise therapy alone. 2. Can be used as a second-line drug for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by sulfonylurea or metformin hydrochloride alone.
Manufacturer:

Shanxi Good Doctor Pharmaceutical Co., Ltd.

Metformin and Glibenclamide Tablets (Ⅰ)
Indication: 1. For patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by diet control and/or exercise therapy alone. 2. Can be used as a second-line drug for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by sulfonylurea or metformin hydrochloride alone.
Manufacturer:

Zhejiang Zhebei Pharmaceutical Co., Ltd.

Metformin and Glibenclamide Tablets (Ⅰ)
Indication: It can be used as a second-line treatment for patients with type 2 diabetes who have not been able to satisfactorily control their blood sugar levels with diet control and exercise plus metformin or sulfonylurea drugs.
Manufacturer:

Chengdu Hengrui Pharmaceutical Co., Ltd.

Metformin Glibenclamide Capsules (Ⅰ)
Indication: 1. For patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by diet control and/or exercise therapy alone. 2. Can be used as a second-line drug for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by sulfonylurea or metformin hydrochloride alone.
Manufacturer:

Qingdao Double Whale Pharmaceutical Co., Ltd.

Metformin Glipizide Tablets
Indication: When using this product alone, it is recommended to combine it with diet and exercise therapy to achieve the effect of controlling blood sugar in non-insulin-dependent (type 2) diabetes. This product can also be used in combination with sulfonylurea hypoglycemic drugs or insulin to control type 2 diabetes.
Manufacturer:

Chengdu Tongde Pharmaceutical Co., Ltd.

Metformin Hydrochloride Tablets
Indication: 1. This product is first used for type 2 diabetes that is ineffective with simple diet control and physical exercise, especially obese type 2 diabetes. 2. For type 1 or type 2 diabetes, this product combined with insulin can increase the hypoglycemic effect of insulin, reduce insulin dosage, and prevent hypoglycemia. 3. This product can also be used in combination with sulfonylurea oral hypoglycemic drugs to have a synergistic effect.
Manufacturer:

SINO-AMERICAN Shanghai Squibb Pharmaceuticals Ltd.

Metformin Hydrochloride Tablets
Indication: 1. This product is first used for type 2 diabetes that is ineffective with simple diet control and physical exercise, especially obese type 2 diabetes. 2. For type 1 or type 2 diabetes, this product combined with insulin can increase the hypoglycemic effect of insulin, reduce insulin dosage, and prevent hypoglycemia. 3. This product can also be used in combination with sulfonylurea oral hypoglycemic drugs to have a synergistic effect.
Manufacturer:

SINO-AMERICAN Shanghai Squibb Pharmaceuticals Ltd.

Metformin and Glibenclamide Tablets (Ⅰ)
Indication: 1. For patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by diet control and/or exercise therapy alone. 2. Can be used as a second-line drug for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by sulfonylurea or metformin hydrochloride alone.
Manufacturer:

Yantai Dongcheng Dayang Pharmaceutical Co., Ltd.

Metformin and Glibenclamide Tablets (Ⅰ)
Indication: 1. For type 2 diabetes patients whose blood sugar levels are not satisfactorily controlled by simple diet control and/or exercise therapy. 2. Can be used as a second-line drug for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by single sulfonylurea or metformin hydrochloride therapy.
Manufacturer:

Zhejiang Zhenyuan Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.